KALV Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 115296 min ago

@ $14.93

Wydano: 14 vas. 2024 @ 21:24

Zwrot: -18.73%

Poprzedni sygnał: vas. 14 - 19:07

Poprzedni sygnał: Sprzedaż

Zwrot: -1.62 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs...

Stats
Dzisiejszy wolumen	199 656
Średni wolumen	788 167
Kapitalizacja rynkowa	511.74M
EPS	$0 ( 2024-03-14 )
Następna data zysków	( $-0.690 ) 2024-07-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.89
ATR14	$0.0150 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Fairey William	Buy	17 000	Stock Option (Right to Buy)
2024-04-18	Fairey William	Buy	0
2024-03-06	Palleiko Benjamin L	Buy	250 000	Restricted Stock Unit
2024-02-20	Venrock Healthcare Capital Partners Iii, L.p.	Buy	655 738	Pre-Funded Warrants (Right to Buy)
2024-02-17	Feener Edward P.	Buy	18 788	Common Stock

INSIDER POWER
66.06
Last 98 transactions
Buy: 3 056 025 \| Sell: 628 012

Wolumen Korelacja

Długi: -0.01 (neutral)

Krótki: 0.15 (neutral)

Signal:(71.589) Neutral

Kalvista Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
ACLS	0.953
BWMN	0.951
NVCN	0.949
NVAC	0.947
CRUS	0.947
TETC	0.947
XFIN	0.946
FOCS	0.944
JMAC	0.943
GENQ	0.941

10 Najbardziej negatywne korelacje
NAKD	-0.955
AMGN	-0.935
THMA	-0.932
BHTG	-0.93
LGMK	-0.926
PCSA	-0.925
AHPI	-0.924
TRIT	-0.918
CREG	-0.911
PLIN	-0.907

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kalvista Pharmaceuticals Korelacja - Waluta/Towar

-0.45
( neutral )

-0.12
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.22
( neutral )

0.42
( neutral )

Kalvista Pharmaceuticals Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-802 000 (0.00 %)
EPS:	$-2.68

FY	2023
Przychody:	$0
Zysk brutto:	$-802 000 (0.00 %)
EPS:	$-2.68

FY	2022
Przychody:	$0
Zysk brutto:	$-743 000 (0.00 %)
EPS:	$-2.80

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.42

Financial Reports:

No articles found.

Kalvista Pharmaceuticals

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.